Sinoway Industrial Co.LTD.

Edoxaban

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;DU 176b;

• CAS NO :

  480449-70-5

• EC NO :

• Molecular Formula :

  C₂₄H₃₀ClN₇O₄S

• Molecular Weight :

  548.06

• Main Specifications :

  99% up

• Packing :

  25kg/drum

• Product description :

  Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. Edoxaban (tosylate Monohydrate) was also approved by the FDA in January 2015 for the prevention of stroke and non-central-nervous-system systemic embolism.

• Uses :

  Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor.

• Molecular Structure :